Keith W. Pfeil - 01 Jul 2021 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
SVP, Chief Financial Officer
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
01 Jul 2021
Net transactions value
-$20,125
Form type
4
Filing time
06 Jul 2021, 17:14:37 UTC
Previous filing
28 Jun 2021
Next filing
20 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $44,374 +833 $53.27 833 01 Jul 2021 Direct
transaction GMED Class A Common Stock Sale $64,499 -833 -100% $77.43 0 01 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -833 -3.2% $0.000000 25,000 01 Jul 2021 Class A Common Stock 833 $53.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2 These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.